Latest Asx News

Pepper Money Limited has announced a fully franked special dividend of 12.5 cents per share, reflecting its robust cash position and ongoing capital management strategy. The payout totals approximately $55.5 million, with key dates set for June and July 2025.

Paradigm Biopharmaceuticals has reached key milestones in its global Phase 3 trial for knee osteoarthritis, activating its first Australian clinical site and enrolling the first patient. With multiple sites in Australia and the US preparing for recruitment, the trial is advancing steadily toward critical data readouts.

Savannah Goldfields has announced a promising new gold Exploration Target at its Big Reef Deposit within the Georgetown Project, potentially extending its resource base and supporting imminent mining plans.

IDP Education has revised its FY25 guidance, forecasting a sharp decline in student placements and language testing volumes due to persistent immigration policy uncertainty across key markets including the UK, Australia, Canada, and the US.

Strickland Metals has reported a significant high-grade gold intercept at its Gradina Prospect within the Rogozna Project, Serbia, advancing its maiden resource plans.

ALS Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to A$30,000 in new shares at a discounted price, following a recent $350 million institutional placement.

Equinox Resources has validated refinery-grade bauxite with strong extractable alumina and notable gallium concentrations at its Campo Grande Project in Brazil, reinforcing its position in the critical minerals sector.

Autosports Group has inked a $350 million syndicated revolving credit facility, streamlining its capital structure and boosting financial flexibility to support future expansion.

Lefroy Exploration has reported outstanding near-surface gold assay results from its Lucky Strike project, validating resource models and revealing promising high-grade zones. With diamond drilling underway to explore a potential larger Stage 2 pit, the company is advancing its development plans backed by partner funding.

EMVision Medical Devices has activated two additional key sites in its pivotal trial for the emu™ bedside brain scanner, advancing its path toward FDA clearance. These new sites join a growing network of leading stroke centres across the US and Australia.

Lunnon Metals reports promising high-grade gold surface samples at its Hustler and Koombana prospects, reinforcing the potential for new discoveries within the Kambalda Gold & Nickel Project. These results pave the way for follow-up drilling and resource expansion alongside the advancing Lady Herial deposit.

Antares Metals has revealed a significant new copper discovery named ‘Marvel’ near its Surprise Copper Mine in Queensland, potentially doubling the project’s mineralised footprint. The company prepares for a third drilling phase to further explore this promising target.